Some judge will have the distinct honor of refereeing this fight for the rights to a controversial stem cell product. Who cares how many viable mesenchymal cells there are, its all about the benjamins. Will Orthofix be able to defend itself in a court of law to retain its right to sell Trinity, or will the Russian Bear look to take down another opponent? You know in some respects a leopard never changes his spots. Remember what TSB says, payback is a bitch. But when you make predictions to the street you must do anything to ascertain your objectives. The Street loves a confident and brash leader, yet still waters run deep. In all likelihood the chalk eaters will be betting NuVasive. Yet, as this case develops TSB can see someone hedging their bet based on the probability of a trial, but this could be a pick em. Lukianov could have fired off a teaser hoping to improve the point spread when he announced his intent to litigate with Orthofix.
TSB wants to know who do our readers believe is the "pup" in this event? Is it Orthofix? And if so, what are the potential scenarios that will develop. Will there be a KO? Will it be a TKO resulting in a revised licensing agreement? Or, will it be a draw? Never in a court of law. So does the "Beast from the East" have the stamina to float like a butterfly and sting like a bee, or, will it be the Primo Carnera of the spine world that throws the best punch? TSB wants to know what our readers think?
The real question is, how did ofix lose Trinity to Nuvasive in the first place? It was one of the few products that seperated them from the other "me too" companies. It seems like they would have held a death grip on that product.
ReplyDeleteNuvasive has always impressed me with the way they have seperated themselves from the other "wanna be's" in the spine world...though, I really have to scratch my head on this one. Osteocel is nothing but cancellous bone rinsed with saline...ie rinsed fresh frozen bone...They have no leg to stand on as the Osirus patents are weak and should not have been granted. Nuvasive will lose the suit and also, their IP will be declared invalid. So much for the brilliance of paying $135 million for it and then suing to expose themselves. I really expect more from a leader like Nuvasive.
ReplyDeleteOsteocel is more smoke and mirrors. Show me the clinical data!!! It's unbelievable how many of the Nuvasive reps claim "it works just as well as BmP, but half the cost" (not true).
ReplyDeleteThe truth will ultimately be known. Just like the BMP pseudoscience will shortly be shown for what it is not, the claims that are made with these products will also be proven out. Disgrace on all the physicians for not understanding the science, or lack thereof, for either of these product.
ReplyDeleteEinstein said it best; science without religion is lame, and religion without science is blind. Meaning, those who proceed down the scientific road without morals are crippled, and religion without science doesn’t see the grand and glorious world that is without question the most intricate, complicated design ever CREATED.
Will someone stand up to all this madness? Science is not a matter of opinion; it is proven over and over and over again. It’s not a consensus of doctors, sales reps, or executives that make something true (or consulting fees), its science. Learning one truth in 7th grade science class and the other in Sunday school was my experience. Perhaps we should have a little more of both.
Road kill is not worth fighting over!If you win you lose, both will stink after it's all said and done.
ReplyDeleteMaybe you need to go back to 7th grade and study some more Anonymous. How can you say BMP is a pseudoscience? Whether you or myself agree with their appropriate uses, these products have helped revolutionize modern spine surgery.
ReplyDeleteRevolutionized? If this is a revolution we are in trouble!
ReplyDeleteSeen plenty of CTs of osteocel plus over the past year. There's a reason some many surgeons are switching to it. It works, and NuVasive is apparently putting studys together now to show. Heard there are upcoming articles going to be published in spine journal. As a Neuro who's switched from infuse and BMA's, I have done my own research and have been very surprised w the fusion results. Especially w smokers.
ReplyDeleteI agree with Anon 10:53 from 5/4/10. If Osteocel was more than cancellous bone rinsed with saline, then maybe Nuvasive has a shot. Nuvasive is going to lose this one...
ReplyDeleteTo anonymous 3:19,
ReplyDeleteIf Nuvasive is putting the studies together, then they must be true of Nuvasive's products, right? And to claim you have done your own research means you are a surgeons who feels your anecdotal experience surpasses the published, peer reviewed studies. So you've seen CT's where Osteocel was used and there is bone growing, big freaking deal. Vitoss has a truckload of such CT's, but that only proves that people will heal most of the time despite what you put in there.
I don't sell BMP but you cannot argue with the science or the fact that it grows bone. So much so that you must be careful in how you use it.